In June, I wrote a post for this very blog that asked, “Is Dendreon (DNDN) done?” Today, we got an answer. The once high-flying biotech company announced it has filed for bankruptcy, sending the already ravaged stock plunging 75% to 24 cents a share. Dendreon filed for chapter 11 bankruptcy protection Monday after shaking hands [...]